The IND Journey Phase I – Navigating Success
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Navigating research compliance often means addressing unseen challenges. Explore strategies to identify blind spots and strengthen oversight frameworks.
Most organizations understand the importance of creating a competitive advantage with a targeted, aggressive hiring strategy – but why is
New to the process of helping to bring a drug to market? As intimidating as the Food and Drug Administration
Now more than ever, there is enormous pressure to deliver products to the market faster and cheaper. In the clinical
An incidental finding is a “finding” or result from an intervention or test that uncovers a condition or problem that
Explore the contributions of clinical trial superheroes, from coordinators to data analysts, improving patient health and outcomes.
Discover how CDOs can balance productivity and quality by exploring agile approaches, benchmarking insights, and key elements of organizational redesign.
In addition to other responsibilities, human subjects protection programs (HRPPs) and IRBs are tasked with ensuring a research protocol’s lifecycle
Since he was young, Sergio Armani has always found solace on the bike, spending many childhood days riding 20 miles
A leading healthcare system partnered with Advarra for a Clinical Research Operations Assessment, enhancing compliance, mitigating risks, and strengthening their HRPP.
The updated European Union (EU) pharmaceutical legislation for the Clinical Trials Regulation (CTR) entered into application on January 1, 2022.
Understanding clinical trial billing rules, from Medicare policies to state laws, is crucial for avoiding compliance pitfalls and supporting trial integrity.